Eli Lilly reports positive data in Phase 3 trial of weight-loss drug as treatment for sleep apnea
Zepbound reduced apnea effect by up to 63% and achieved about 20% weight loss after a year.
Gold demand marked its strongest first quarter in eight years, buoyed by “healthy investment” from the over-the-counter market as well...
HSBC on Tuesday said its chief executive, Noel Quinn, will retire after nearly five years at the helm.
China Vanke posted a first-quarter loss as earnings were weighed by the ongoing slump in China’s property sector.
Peacock is raising prices again, a year after its last price hike and just in time for the Summer Olympics.
Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms...
Shares of Coursera Inc. and Chegg Inc. fell in the after-hours session Monday after both education-tech companies guided for weaker...
Average Rating